Hologic completes FluoroScan purchase
Bone densitometry firm Hologic last month finalized its purchaseof mini C-arm developer FluoroScan Imaging Systems of Northbrook,IL (SCAN 7/31/96). Hologic, of Waltham, MA, completed the acquisitionthrough a stock swap, in which each share of FluoroScan
Bone densitometry firm Hologic last month finalized its purchase
of mini C-arm developer FluoroScan Imaging Systems of Northbrook,
IL (SCAN 7/31/96). Hologic, of Waltham, MA, completed the acquisition
through a stock swap, in which each share of FluoroScan stock
was exchanged for 0.31069 shares of Hologic stock. The acquisition
is the first step in Hologic's strategy to diversify into new
markets, according to chairman and CEO David Ellenbogen.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
